CRIS Q2 2018 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena

CRISCuris, Inc.

$14M

Q2 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M+14.4% YoY

Gross Profit

$2M94.3% margin

Operating Income

-$8M-333.3% margin

Net Income

-$9M-367.4% margin

EPS (Diluted)

$-5.23

QoQ Revenue Growth

-4.5%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$53M

Total Liabilities

$46M

Stockholders' Equity

$7M

Cash & Equivalents

$30M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$2M	+14.4%
Gross Profit	$2M	$2M	+13.2%
Operating Income	-$8M	-$13M	+40.0%
Net Income	-$9M	-$14M	+38.5%

Revenue Segments

Drug Development Royalty

$100,000100%